PEBBLE LABS - Trademark Details
Status: 700 - Registered
Serial Number
88225549
Registration Number
5819332
Word Mark
PEBBLE LABS
Status
700 - Registered
Status Date
2019-07-30
Filing Date
2018-12-11
Registration Number
5819332
Registration Date
2019-07-30
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-05-14
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
ALESKOW, DAVID HOWARD
Statements
Disclaimer with Predetermined Text
"LABS"
Goods and Services
Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Design and development of biological RNA-based therapeutic agents for the prevention and treatment of infectious diseases in plants and animals for use in pharmaceuticals, biotechnology, and medical and diagnostic applications; Research and development of biopharmaceutical compounds; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target pathogen genes in plants and animals; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit aquaculture-related diseases; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit mosquito populations; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of genetically engineered organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target pathogen genes in plants and animals; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit aquaculture-related diseases; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit mosquito populations; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce that produce eukaryotic-like mRNA; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce that produce commercial compounds; Research and development of genetically engineered organisms, namely, genetically engineered algae that produce that produce waxes; Research and development of pharmaceuticals, therapeutics, and biologics; Research and development of new biological products for therapeutic use
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-01-03
Primary Code
042
First Use Anywhere Date
2018-01-07
First Use In Commerce Date
2018-01-07
Current Trademark Owners
Party Name
Party Type
32 - 2nd New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
32 - 2nd New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DAVID S. KERR
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2018-12-14 | NEW APPLICATION ENTERED IN TRAM |
| 2019-01-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-03-08 | ASSIGNED TO EXAMINER |
| 2019-03-14 | EXAMINERS AMENDMENT -WRITTEN |
| 2019-03-14 | EXAMINERS AMENDMENT E-MAILED |
| 2019-03-14 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2019-03-14 | EXAMINER'S AMENDMENT ENTERED |
| 2019-03-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2019-04-05 | ASSIGNED TO LIE |
| 2019-04-10 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2019-04-24 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-05-14 | PUBLISHED FOR OPPOSITION |
| 2019-05-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-07-30 | REGISTERED-PRINCIPAL REGISTER |
| 2019-10-09 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 2021-01-06 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
